Plandai Biotechnology Announces Phytofare to Be Focus of Human Clinical Trial for Type II Diabetes in Mauritius
LONDON, UNITED KINGDOM--(Marketwired - May 16, 2017) - Plandaí Biotechnology, Inc. (OTC PINK: PLPL) ("Plandaí" or "the Company"), producer of the highly bioavailable Phytofare® Catechin Complex, today announced that its green tea …